Literature DB >> 24926973

Socioeconomic patterning in the incidence and survival of children and young people diagnosed with malignant melanoma in northern England.

Richard J Q McNally1, Nermine O Basta2, Steven Errington2, Peter W James2, Paul D Norman3, Alan W Craft4.   

Abstract

Previous studies have found marked increases in melanoma incidence. The increase among young people in northern England was especially apparent among females. However, overall 5-year survival has greatly improved. The present study aimed to determine whether socioeconomic factors may be involved in both etiology and survival. All 224 cases of malignant melanoma diagnosed in patients aged 10-24 years during 1968-2003 were extracted from a specialist population-based regional registry. Negative binomial regression was used to examine the relationship between incidence and area-based measures of socioeconomic deprivation and small-area population density. Cox regression was used to analyze the relationship between survival and deprivation and population density. There was significantly decreased risk associated with living in areas of higher unemployment (relative risk per 1% increase in unemployment=0.93; 95% confidence interval (CI) 0.90-0.96, P<0.001). Survival was better in less deprived areas (hazard ratio (HR) per tertile of household overcrowding=1.52; 95% CI 1.05-2.20; P=0.026), but this effect was reduced in the period 1986-2003 (HR=0.61; 95% CI 0.40-0.92; P=0.018). This study found that increased risk of melanoma was linked with some aspects of greater affluence. In contrast, worse survival was associated with living in a more deprived area.

Entities:  

Mesh:

Year:  2014        PMID: 24926973     DOI: 10.1038/jid.2014.246

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  20 in total

1.  Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006.

Authors:  Simple D Singh; Umed A Ajani; Christopher J Johnson; Katherine B Roland; Melody Eide; Ahmedin Jemal; Serban Negoita; Rana A Bayakly; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

2.  Seasonal variation in the month of birth in teenagers and young adults with melanoma suggests the involvement of early-life UV exposure.

Authors:  Nermine O Basta; Peter W James; Alan W Craft; Richard J Q McNally
Journal:  Pigment Cell Melanoma Res       Date:  2010-11-02       Impact factor: 4.693

3.  A review of human carcinogens--part D: radiation.

Authors:  Fatiha El Ghissassi; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Véronique Bouvard; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-08       Impact factor: 41.316

Review 4.  Diagnosis and management of nevi and cutaneous melanoma in infants and children.

Authors:  Cybele Fishman; Martin C Mihm; Arthur J Sober
Journal:  Clin Dermatol       Date:  2002 Jan-Feb       Impact factor: 3.541

5.  Association between functional polymorphism in EGF gene and malignant melanoma.

Authors:  Majid Shahbazi; Vera Pravica; Najma Nasreen; Hana Fakhoury; Anthony A Fryer; Richard C Strange; Peter E Hutchinson; Joy E Osborne; John T Lear; Andrew G Smith; Ian V Hutchinson
Journal:  Lancet       Date:  2002-02-02       Impact factor: 79.321

6.  Regional melanoma incidence in England, 1996-2006: reversal of north-south latitude trends among the young female population.

Authors:  S C Wallingford; R D Alston; J M Birch; A C Green
Journal:  Br J Dermatol       Date:  2013-10       Impact factor: 9.302

7.  Cancer in young people in the north of England, 1968-85: analysis by census wards.

Authors:  A W Craft; L Parker; S Openshaw; M Charlton; J Newell; J M Birch; V Blair
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

8.  Childhood malignant melanoma. Incidence and etiology.

Authors:  J L Bader; F P Li; P M Olmstead; N A Strickman; D M Green
Journal:  Am J Pediatr Hematol Oncol       Date:  1985

9.  Recent trends in incidence of cutaneous melanoma among US Caucasian young adults.

Authors:  Mark P Purdue; Laura E Beane Freeman; William F Anderson; Margaret A Tucker
Journal:  J Invest Dermatol       Date:  2008-07-10       Impact factor: 8.551

10.  Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.

Authors:  M P Coleman; B Rachet; L M Woods; E Mitry; M Riga; N Cooper; M J Quinn; H Brenner; J Estève
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

View more
  9 in total

1.  The role of spatially-derived access-to-care characteristics in melanoma prevention and control in Los Angeles county.

Authors:  Loraine A Escobedo; Ashley Crew; Ariana Eginli; David Peng; Michael R Cousineau; Myles Cockburn
Journal:  Health Place       Date:  2017-04-06       Impact factor: 4.078

2.  Melanoma in women of childbearing age and in pregnancy in California, 1994-2015: a population-based cohort study.

Authors:  M Kiuru; Q Li; G Zhu; J R Terrell; K Beroukhim; E Maverakis; T H M Keegan
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-08-23       Impact factor: 9.228

3.  Long Noncoding RNA CCAT1 Functions as a Competing Endogenous RNA to Upregulate ITGA9 by Sponging MiR-296-3p in Melanoma.

Authors:  Jinghua Fan; Xiaoxiao Kang; Limin Zhao; Yan Zheng; Jun Yang; Di Li
Journal:  Cancer Manag Res       Date:  2020-06-18       Impact factor: 3.989

4.  The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a.

Authors:  Li Lv; Jian-Qin Jia; Jin Chen
Journal:  Oncol Res       Date:  2017-04-12       Impact factor: 5.574

5.  Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults.

Authors:  Michael Roth; Melissa Beauchemin; Justine M Kahn; Archie Bleyer
Journal:  Cancer Med       Date:  2021-09-30       Impact factor: 4.452

6.  ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/ β-catenin signaling pathway.

Authors:  Yanqiu Bao; Jingshu Cui; Yuyang Yue; Shuxia Cao; Xiangdan Li; Lan Liu
Journal:  Cancer Cell Int       Date:  2022-01-29       Impact factor: 5.722

7.  Silencing LINC00665 inhibits cutaneous melanoma in vitro progression and induces apoptosis via the miR-339-3p/TUBB.

Authors:  Yi Liu; Shanshan Ma; Qichao Ma; Haigang Zhu
Journal:  J Clin Lab Anal       Date:  2022-08-05       Impact factor: 3.124

8.  Influence of socioeconomic factors and region of residence on cancer stage of malignant melanoma: a Danish nationwide population-based study.

Authors:  Else Helene Ibfelt; Marianne Steding-Jessen; Susanne Oksbjerg Dalton; Sanne Lykke Lundstrøm; Merete Osler; Lisbet Rosenkrantz Hölmich
Journal:  Clin Epidemiol       Date:  2018-07-10       Impact factor: 4.790

9.  Bergamottin Induces DNA Damage and Inhibits Malignant Progression in Melanoma by Modulating miR-145/Cyclin D1 Axis.

Authors:  Zhongfang Zhao; Nong Liao
Journal:  Onco Targets Ther       Date:  2021-06-17       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.